Template:SubstanceBox/Sufentanil: Difference between revisions
From Drugwiki
Common names correctly annotated. |
m 1 revision imported |
||
(No difference)
| |||
Latest revision as of 14:15, 1 November 2025
{{#arraydefine: InhaledDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: InhaledDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: SmokedDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: SmokedDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: OralDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: OralDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: SublingualDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: SublingualDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: BuccalDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: BuccalDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: InsufflatedDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: InsufflatedDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: RectalDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: RectalDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: TransdermalDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: TransdermalDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: SubcutaneousDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: SubcutaneousDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: IntramuscularDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: IntramuscularDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: IntravenousDosage |
Threshold;Intravenous threshold dose::0.1Intravenous dose units::μg,
Light;Intravenous min light dose::1 - Intravenous max light dose::5 μg,
Common;Intravenous min common dose::5 - Intravenous max common dose::10 μg,
Strong;Intravenous min strong dose::10 - Intravenous max strong dose::25 μg,
Heavy;Intravenous heavy dose::25 μg +
}}
{{#arraydefine: IntravenousDuration |
Total;,
Onset;Intravenous min onset time::1 - Intravenous max onset time::2Intravenous onset time units::minutes,
Come up;,
Peak;Intravenous min peak time::5 - Intravenous max peak time::10Intravenous peak time units::minutes,
Offset;,
After effects;Intravenous min aftereffects time::1 - Intravenous max aftereffects time::12Intravenous aftereffects time units::hours
}}
{{#arraydefine: uncertaininteractions
| {{#ask:SubstanceBox/Sufentanil
|?UncertainInteraction
|headers=hide
|format=list
|mainlabel=-
|link=none
}}
}}
{{#arraydefine: unsafeinteractions
| {{#ask:SubstanceBox/Sufentanil
|?UnsafeInteraction
|headers=hide
|format=list
|mainlabel=-
|link=none
}}
}}
{{#arraydefine: dangerousinteractions
| {{#ask:SubstanceBox/Sufentanil
|?DangerousInteraction
|headers=hide
|format=list
|mainlabel=-
|link=none
}}
}} {{#arrayprint:uncertaininteractions||@@@@|
}} {{#arrayprint:unsafeinteractions||@@@@|
}} {{#arrayprint:dangerousinteractions||@@@@|
}}
| SubstanceBox/Sufentanil | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemical Nomenclature | |||||||||||||||
| Common names | common name::Sufentanil, common name::Sufentanyl, common name::Sufenta, common name::Chronogesic, | ||||||||||||||
| Systematic name | N-[4-(Methoxymethyl)-1-(2-thiofuran-2-ylethyl)-4-piperidyl]-N-phenylpropanamide | ||||||||||||||
| Class Membership | |||||||||||||||
| Psychoactive class | Psychoactive class::Opioid | ||||||||||||||
| Chemical class | Chemical class::Anilidopiperidine | ||||||||||||||
| Routes of Administration | |||||||||||||||
|
|||||||||||||||
| Interactions | |||||||||||||||
| @@@@ | |||||||||||||||
| @@@@ | |||||||||||||||
| @@@@ | |||||||||||||||
